Technical Strength Analyser      Futures Screeners ,    Option Screeners
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Fundamental Analysis of Shilpa Medicare (SHILPAMED)

Summary    Balance Sheet    Cash Flow    Income    Qtrly Income    Risk    Profitability    Qtrly Profit    Solvency    

You can now fully customise Watchlist by choosing any combination of your favorites Technical And Fundamental parameter.

Financial Highlights SHILPAMED

EOD Close 457.30
Market Cap 3642.62
EBITDA 209.12
Book Value 154.001
Profit margin 0.164
Qtr Revenue Growth YOY 0.366
Qtr Earning Growth YOY 3.62
Revenue TTM 887.55
Gross Profit TTM 448.52
Revenue Per Share TTM 108.86
Face Value 1.00
Enterprise Value 984.94
Outstanding Shares 8.15
Consensus Target 0

Key Ratios of SHILPAMED

Earning /Share 17.84
Diluted EPS TTM 17.84
PE Ratio 24.99
Div / Share 1.00
Div Yield % 0.200
PEG Ratio 0
Trailing PE 24.99
Forward PE 0
Price Sales TTM 0
Price Book MRQ 2.89
Enterprise Value / Revenue 19.99
Enterprise Value / EBITDA 4.71
Return on Asset TTM 0.0445
Return on Equity TTM 0.083

Key Balance Sheet Fields

Period 31_Mar_2019 31-Mar-18 Growth
Common Stock 8.15 8.15 0 %
Current Liabilities 253.54 265.84 4.63 %
Total Liabilities 420.16 419.32 0.200 %
Current Assets 545.16 671.97 18.87 %
Total Assets 1610.12 1499.13 7.40 %
Working capital 291.62 406.13 28.20 %
Accounts Payable 82.58 103.74 20.40 %
Inventory 187.67 188.71 0.551 %
Net Receivable 245.59 252.18 2.61 %
   
   

Key Cash Flow Fields

Period 31_Mar_2019 31_Mar_2018 Growth
Cash EPS 18.73 17.34 8.02 %
Cash From Investment Activity -188.15 -8.76 2047.83 %
Cash From Financial Activity 10.06 -60.91 116.52 %
Cash Operational Activity 138.76 44.92 208.90 %
Net Cash Flow -39.32 -24.75 58.87 %
NetIncome 112.26 105.24 6.67 %
Capital Expenditure 299.97 137.98 117.40 %
Change To Inventory 1.04 1.29 19.38 %
   
   



Annual Key Income Statement of SHILPAMED

Period 31_Mar_2019 31_Mar_2018 Growth
Net Income From Continuing Ops 109.50 102.86 6.46 %
Net Income 112.26 105.24 6.67 %
Operating Income 114.08 114.75 0.584 %
Total Revenue 733.66 789.40 7.06 %
Operating Expense 619.58 674.65 8.16 %
Interest Expense -3.68 -2.66 38.35 %
Tax Expense 26.18 33.91 22.80 %
Income Before tax 135.68 136.77 0.797 %
Gross Profit 448.52 412.86 8.64 %
Dividend Paid 0 -7.23 100.00 %
   
   

Quarterly Key Income Statement of SHILPAMED

Period 31_Dec_2019 30_Sep_2019 Growth
Net Income From Continuing Ops 54.92 50.48 8.80 %
Net Income 55.06 50.78 8.43 %
Operating Income 62.78 57.34 9.49 %
Total Revenue 236.85 289.92 18.31 %
Operating Expense 174.08 232.58 25.15 %
Interest Expense -1.27 -0.818 55.26 %
Tax Expense 10.53 11.19 5.90 %
Income Before tax 65.45 61.66 6.15 %
Gross Profit 173.10 197.74 12.46 %
Dividend Paid 0 0 � %
   
   




About Financial Data , All results are consolidated, Values are in Crores, Sourced from external Vendors


( Intraday Analysis is on 15 Mins Delayed Data. All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.